Skip to Main Content

Advertisement

Skip Nav Destination

OnlineFirst

Research Article May 12 2022
Biomarker Development: Bedside to Bench
Clin Cancer Res (2022)
Research Article May 10 2022
An autologous dendritic cell vaccine promotes anticancer immunity in ovarian cancer patients with low mutational burden and cold tumors
Clin Cancer Res clincanres.4413.2021.
Research Article May 9 2022
Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer
Clin Cancer Res (2022)
Research Article May 9 2022
Linking Genotype to Phenotype: Bench to Bedside
Clin Cancer Res (2022)
Review Article May 9 2022
Combining Targeted Radionuclide Therapy and Immune Checkpoint Inhibition for Cancer Treatment
Clin Cancer Res (2022)
Research Article May 6 2022
MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian Carcinoma
Clin Cancer Res (2022)
Review Article May 6 2022
The Need for New Treatments Targeting MPNST: The Potential of Strategies Combining MEK Inhibitors with Antiangiogenic Agents
Clin Cancer Res (2022)
Research Article May 6 2022
Shall We Dance: Evolving Partnerships of Targeted Therapies for AML
Clin Cancer Res (2022)
Research Article May 4 2022
A Randomized Ph2 Study of MEDI0680 in Combination With Durvalumab vs. Nivolumab Monotherapy in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma
Clin Cancer Res clincanres.4115.2021.
Research Article May 3 2022
The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma
Clin Cancer Res (2022)
Research Article May 3 2022
Single-Cell RNA Sequencing Unveils the Clonal and Transcriptional Landscape of Cutaneous T-Cell Lymphomas
Clin Cancer Res (2022)
Research Article May 3 2022
Spatial Metabolomics Identifies Distinct Tumor-Specific Subtypes in Gastric Cancer Patients
Clin Cancer Res (2022)
Research Article May 3 2022
Report of the First International Symposium on NUT Carcinoma
Clin Cancer Res (2022)
Research Article May 3 2022
What's in a Name? That Which We Call Immune Cells by Any Other Name Would All Smell as Sweet
Clin Cancer Res (2022)
Research Article April 29 2022
FDA Approval Summary: Decitabine and Cedazuridine Tablets for Myelodysplastic Syndromes
Clin Cancer Res (2022)
Research Article April 29 2022
Malic Enzyme 1 Absence in Synovial Sarcoma Shifts Antioxidant System Dependence and Increases Sensitivity to Ferroptosis Induction with ACXT-3102
Clin Cancer Res (2022)
Research Article April 29 2022
Alpha-Fetoprotein as a Potential Surrogate Biomarker for Atezolizumab + Bevacizumab Treatment of Hepatocellular Carcinoma
Clin Cancer Res (2022)
Research Article April 29 2022
Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial
Clin Cancer Res (2022)
Research Article April 29 2022
Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma
Clin Cancer Res (2022)
Research Article April 29 2022
Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer
Clin Cancer Res (2022)
Research Article April 29 2022
Exploratory Study of NPC-0501 Trial: Optimal Cisplatin Dose of Concurrent and Induction/Adjuvant Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma
Clin Cancer Res (2022)
Research Article April 29 2022
Dose- and Volume-Limiting Late Toxicity of FLASH Radiotherapy in Cats with Squamous Cell Carcinoma of the Nasal Planum and in Mini Pigs
Clin Cancer Res (2022)
Review Article April 29 2022
Immunotherapy of Neuroblastoma: Facts and Hopes
Clin Cancer Res (2022)
Research Article April 29 2022
Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma
Clin Cancer Res (2022)
Research Article April 29 2022
Lenalidomide and the Expanding Toolkit to Manage Kaposi Sarcoma
Clin Cancer Res (2022)
Research Article April 25 2022
Rapid Screening Using Pathomorphologic Interpretation to Detect BRAFV600E Mutation and Microsatellite Instability in Colorectal Cancer
Clin Cancer Res (2022)
Research Article April 25 2022
Targeting Podoplanin for the Treatment of Osteosarcoma
Clin Cancer Res (2022)
Review Article April 25 2022
Intratumor Heterogeneity and Antitumor Immunity Shape One Another Bidirectionally
Clin Cancer Res (2022)
Research Article April 25 2022
Sounding the Alarm on Leiomyosarcoma Recurrence: Role of Circulating Tumor DNA
Clin Cancer Res (2022)
Research Article April 21 2022
Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
Clin Cancer Res (2022)
Research Article April 21 2022
Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing Program
Clin Cancer Res (2022)
Research Article April 21 2022
Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
Clin Cancer Res (2022)
Research Article April 21 2022
Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma
Clin Cancer Res (2022)
Research Article April 21 2022
A Phase 1/2 Trial Combining Avelumab and Trabectedin for Advanced Liposarcoma and Leiomyosarcoma
Clin Cancer Res (2022)
Research Article April 21 2022
Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC
Clin Cancer Res (2022)
Research Article April 21 2022
Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma
Clin Cancer Res (2022)
Research Article April 21 2022
An Ascendant Challenge: Central Nervous System Metastases in ALK+ Lung Cancers
Clin Cancer Res (2022)
Research Article April 18 2022
VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
Clin Cancer Res (2022)
Research Article April 14 2022
Predicting the Future: Machine-Based Learning for MRD Prognostication
Clin Cancer Res (2022)
Research Article April 14 2022
Release of IFNγ by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells
Clin Cancer Res (2022)
Brief Report April 14 2022
Phase II Study of Ramucirumab in Advanced Biliary Tract Cancer Previously Treated By Gemcitabine-Based Chemotherapy
Clin Cancer Res (2022)
Research Article April 14 2022
Venetoclax Cooperates with Ionizing Radiation to Attenuate Diffuse Midline Glioma Tumor Growth
Clin Cancer Res (2022)
Research Article April 14 2022
Preclinical Modeling of Leiomyosarcoma Identifies Susceptibility to Transcriptional CDK Inhibitors through Antagonism of E2F-Driven Oncogenic Gene Expression
Clin Cancer Res (2022)
Research Article April 14 2022
Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment Response
Clin Cancer Res (2022)
Research Article April 14 2022
First Clinical Results of Fluorescence Lifetime-Enhanced Tumor Imaging Using Receptor-targeted Fluorescent Probes
Clin Cancer Res (2022)
Research Article April 14 2022
PARPs: All for One and One for All? Enhancing Diversity in Clinical Trials
Clin Cancer Res (2022)
Research Article April 14 2022
Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer
Clin Cancer Res (2022)
Research Article April 12 2022
Preclinical and Pilot Study of Type I FLT3 Tyrosine Kinase Inhibitor, Crenolanib, with Sorafenib in Acute Myeloid Leukemia and FLT3-Internal Tandem Duplication
Clin Cancer Res (2022)
Research Article April 12 2022
Prognostic and Predictive Factors in Patients with Advanced HCC and Elevated Alpha-Fetoprotein Treated with Ramucirumab in Two Randomized Phase III Trials
Clin Cancer Res (2022)
Research Article April 12 2022
Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence: a Report from the EORTC 26091 TAVAREC Trial
Clin Cancer Res (2022)
Page 2 of 3
Close Modal

or Create an Account

Close Modal
Close Modal